Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars.
Gabriela Bittencourt Gonzalez MoseguiFernando AntõnanzasCid Manso de Mello ViannaPaula RojasPublished in: Advances in rheumatology (London, England) (2021)
The economic effort that LA countries make to access these medicines is much higher than the US and Spain. The use of the PPP ensured a better understanding of the actual access to these inputs in the countries analyzed.